{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:03:41Z","timestamp":1791821021969,"version":"4.3.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,8,6]],"date-time":"2014-08-06T00:00:00Z","timestamp":1407283200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s12328-014-0518-y","type":"journal-article","created":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T15:38:56Z","timestamp":1407253136000},"page":"434-440","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Asynchronous leptomeningeal carcinomatosis from pancreatic cancer: a case report and review of the literature"],"prefix":"10.1007","volume":"7","author":[{"given":"Christopher S.","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habibe","family":"Kurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Bradley","family":"Elder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,6]]},"reference":[{"key":"518_CR1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02341153","volume":"9","author":"JG Kaplan","year":"1990","unstructured":"Kaplan JG, DeSouza TG, Farkash A, et al. Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol. 1990;9:225\u20139.","journal-title":"J Neurooncol"},{"key":"518_CR2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0733-8619(02)00032-4","volume":"21","author":"S Kesari","year":"2003","unstructured":"Kesari S, Batchelor TT. Leptomeningeal metastases. Neurol Clin. 2003;21:25\u201366.","journal-title":"Neurol Clin"},{"key":"518_CR3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11060-010-0524-y","volume":"104","author":"CRAS Azevedo de","year":"2011","unstructured":"de Azevedo CRAS, Cruz MRS, Chinen LTD, et al. Meningeal carcinomatosis in breast cancer: prognostic factors and outcome. J Neurooncol. 2011;104:565\u201372.","journal-title":"J Neurooncol"},{"key":"518_CR4","first-page":"811","volume":"37","author":"H Rudnicka","year":"2003","unstructured":"Rudnicka H, Niwi\u0144ska A, Gruszfeld A, et al. Diagnosis and treatment of carcinoid meningitis: a challenge to the neurologist and oncologist. Neurol Neurochir Pol. 2003;37:811\u201324.","journal-title":"Neurol Neurochir Pol"},{"key":"518_CR5","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1093\/emboj\/17.12.3351","volume":"17","author":"JE Strong","year":"1998","unstructured":"Strong JE, Coffey MC, Tang D, et al. The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus. EMBO J. 1998;17:3351\u201362.","journal-title":"EMBO J"},{"key":"518_CR6","doi-asserted-by":"crossref","first-page":"11099","DOI":"10.1073\/pnas.0404310101","volume":"101","author":"KL Norman","year":"2004","unstructured":"Norman KL, Hirasawa K, Yang AD, et al. Reovirus oncolysis: the Ras\/RalGEF\/p38 pathway dictates host cell permissiveness to reovirus infection. Proc Natl Acad Sci USA. 2004;101:11099\u2013104.","journal-title":"Proc Natl Acad Sci USA"},{"key":"518_CR7","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1126\/science.282.5392.1332","volume":"282","author":"MC Coffey","year":"1998","unstructured":"Coffey MC, Strong JE, Forsyth PA, et al. Reovirus therapy of tumors with activated Ras pathway. Science. 1998;282:1332\u20134.","journal-title":"Science"},{"key":"518_CR8","doi-asserted-by":"crossref","first-page":"7720","DOI":"10.1038\/sj.onc.1209041","volume":"24","author":"M Shmulevitz","year":"2005","unstructured":"Shmulevitz M, Marcato P, Lee PW. Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer. Oncogene. 2005;24:7720\u20138.","journal-title":"Oncogene"},{"key":"518_CR9","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/mt.2012.146","volume":"20","author":"E Galanis","year":"2012","unstructured":"Galanis E, Markovic SN, Suman VJ, et al. Phase II trial of intravenous administration of Reolysin((R)) (Reovirus Serotype-3-dearing Strain) in patients with metastatic melanoma. Mol Ther. 2012;20:1998\u20132003.","journal-title":"Mol Ther"},{"key":"518_CR10","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s10637-012-9865-z","volume":"31","author":"DG Morris","year":"2013","unstructured":"Morris DG, Feng X, DiFrancesco LM, et al. REO-001: a phase I trial of percutaneous intralesional administration of reovirus type 3 dearing (Reolysin(R)) in patients with advanced solid tumors. Invest New Drugs. 2013;31:696\u2013706.","journal-title":"Invest New Drugs"},{"key":"518_CR11","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1158\/1078-0432.CCR-10-2159","volume":"17","author":"MP Lolkema","year":"2011","unstructured":"Lolkema MP, Arkenau HT, Harrington K, et al. A phase I study of the combination of intravenous reovirus type 3 dearing and gemcitabine in patients with advanced cancer. Clin Cancer Res. 2011;17:581\u20138.","journal-title":"Clin Cancer Res"},{"key":"518_CR12","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1158\/1078-0432.CCR-10-1233","volume":"16","author":"C Comins","year":"2010","unstructured":"Comins C, Spicer J, Protheroe A, et al. REO-10: a phase I study of intravenous reovirus and docetaxel in patients with advanced cancer. Clin Cancer Res. 2010;16:5564\u201372.","journal-title":"Clin Cancer Res"},{"key":"518_CR13","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1158\/1078-0432.CCR-10-0054","volume":"16","author":"KJ Harrington","year":"2010","unstructured":"Harrington KJ, Karapanagiotou EM, Roulstone V, et al. Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers. Clin Cancer Res. 2010;16:3067\u201377.","journal-title":"Clin Cancer Res"},{"key":"518_CR14","doi-asserted-by":"crossref","first-page":"7127","DOI":"10.1158\/1078-0432.CCR-08-0524","volume":"14","author":"L Vidal","year":"2008","unstructured":"Vidal L, Pandha HS, Yap TA, et al. A phase I study of intravenous oncolytic reovirus type 3 dearing in patients with advanced cancer. Clin Cancer Res. 2008;14:7127\u201337.","journal-title":"Clin Cancer Res"},{"key":"518_CR15","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1158\/1078-0432.CCR-11-2181","volume":"18","author":"EM Karapanagiotou","year":"2012","unstructured":"Karapanagiotou EM, Roulstone V, Twigger K, et al. Phase I\/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies. Clin Cancer Res. 2012;18:2080\u20139.","journal-title":"Clin Cancer Res"},{"key":"518_CR16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/A:1005910203831","volume":"38","author":"G Wolfgang","year":"1998","unstructured":"Wolfgang G, Marcus D, Ulrike S. LC: clinical syndrome in different primaries. J Neurooncol. 1998;38:103\u201310.","journal-title":"J Neurooncol"},{"key":"518_CR17","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00019052-200012000-00005","volume":"13","author":"MC Chamberlain","year":"2000","unstructured":"Chamberlain MC. Neoplastic meningitis: a guide to diagnosis and treatment. Curr Opin Neurol. 2000;13:641\u20138.","journal-title":"Curr Opin Neurol"},{"key":"518_CR18","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1590\/S0004-282X2011000700024","volume":"69","author":"SJ Martins","year":"2011","unstructured":"Martins SJ, Azevedo CR, Chinen LT, et al. Meningeal carcinomatosis in solid tumors. Arq Neuropsiquiatr. 2011;69:973\u201380.","journal-title":"Arq Neuropsiquiatr"},{"key":"518_CR19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/archsurg.1995.01430020015001","volume":"130","author":"C Mao","year":"1995","unstructured":"Mao C, Domenico DR, Kim K, et al. Observations on the developmental patterns and the consequences of pancreatic exocrine adenocarcinoma. Findings of 154 autopsies. Arch Surg. 1995;130:125\u201334.","journal-title":"Arch Surg"},{"key":"518_CR20","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00006676-199511000-00005","volume":"11","author":"T Kamisawa","year":"1995","unstructured":"Kamisawa T, Isawa T, Koike M, et al. Hematogenous metastases of pancreatic ductal carcinoma. Pancreas. 1995;11:345\u20139.","journal-title":"Pancreas"},{"key":"518_CR21","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/BF02470607","volume":"16","author":"S Matsuno","year":"1986","unstructured":"Matsuno S, Kato S, Kobari M, et al. Clinicopathological study on hematogenous metastasis of pancreatic cancer. Jpn J Surg. 1986;16:406\u201311.","journal-title":"Jpn J Surg"},{"key":"518_CR22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/jnci\/djp456","volume":"102","author":"Z Gil","year":"2010","unstructured":"Gil Z, Cavel O, Kelly K, et al. Paracrine regulation of pancreatic cancer cell invasion by peripheral nerves. J Natl Cancer Inst. 2010;102:107\u201318.","journal-title":"J Natl Cancer Inst"},{"key":"518_CR23","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1158\/0008-5472.CAN-13-2050","volume":"74","author":"RE Stopczynski","year":"2014","unstructured":"Stopczynski RE, Normolle DP, Hartman DJ, et al. Neuroplastic changes occur early in the development of pancreatic ductal adenocarcinoma. Cancer Res. 2014;74:1718\u201327.","journal-title":"Cancer Res"},{"key":"518_CR24","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.3390\/ijms14024163","volume":"14","author":"J Lemke","year":"2013","unstructured":"Lemke J, Scheele J, Kapapa T, et al. Brain metastasis in pancreatic cancer. Int J Mol Sci. 2013;14:4163\u201373.","journal-title":"Int J Mol Sci"},{"key":"518_CR25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s40263-012-0024-z","volume":"27","author":"R Bartsch","year":"2013","unstructured":"Bartsch R, Berghoff AS, Preusser M. Optimal management of brain metastases from breast cancer. Issues and considerations. CNS Drugs. 2013;27:121\u201334.","journal-title":"CNS Drugs"},{"key":"518_CR26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.blre.2011.12.001","volume":"26","author":"T Siegal","year":"2012","unstructured":"Siegal T, Goldschmidt N. CNS prophylaxis in diffuse large B-cell lymphoma: if, when, how and for whom? Blood Rev. 2012;26:97\u2013106.","journal-title":"Blood Rev"},{"key":"518_CR27","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1634\/theoncologist.8-5-398","volume":"8","author":"EL Chang","year":"2003","unstructured":"Chang EL, Lo S. Diagnosis and management of central nervous system metastases from breast cancer. Oncologist. 2003;8:398\u2013410.","journal-title":"Oncologist"},{"key":"518_CR28","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/cncr.24921","volume":"116","author":"MJ Glantz","year":"2010","unstructured":"Glantz MJ, Van Horn A, Fisher R, et al. Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis. Cancer. 2010;116:1947\u201352.","journal-title":"Cancer"},{"key":"518_CR29","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1212\/WNL.44.8.1463","volume":"44","author":"T Siegal","year":"1994","unstructured":"Siegal T, Lossos A, Pfeffer MR. Leptomeningeal metastases: analysis of 31 patients with sustained off-therapy response following combined-modality therapy. Neurology. 1994;44:1463\u20139.","journal-title":"Neurology"},{"key":"518_CR30","first-page":"3394","volume":"5","author":"MJ Glantz","year":"1999","unstructured":"Glantz MJ, Jaeckle KA, Chamberlain MC, et al. A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res. 1999;5:3394\u2013402.","journal-title":"Clin Cancer Res"},{"key":"518_CR31","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1200\/JCO.1999.17.10.3110","volume":"17","author":"MJ Glantz","year":"1999","unstructured":"Glantz MJ, LaFollette S, Jaeckle KA, et al. Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol. 1999;17:3110\u20136.","journal-title":"J Clin Oncol"},{"key":"518_CR32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.1993.11.3.561","volume":"11","author":"SA Grossman","year":"1993","unstructured":"Grossman SA, Finkelstein DM, Ruckdeschel JC, et al. Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group. J Clin Oncol. 1993;11:561\u20139.","journal-title":"J Clin Oncol"},{"key":"518_CR33","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1200\/JCO.1987.5.10.1655","volume":"5","author":"RN Hitchins","year":"1987","unstructured":"Hitchins RN, Bell DR, Woods RL, et al. A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol. 1987;5:1655\u201362.","journal-title":"J Clin Oncol"},{"key":"518_CR34","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.4103\/2152-7806.111304","volume":"4","author":"E Rhun Le","year":"2013","unstructured":"Le Rhun E, Taillibert S, Chamberlain MC. Carcinomatous meningitis: leptomeningeal metastases in solid tumors. Surg Neurol Int. 2013;4:S265\u201388.","journal-title":"Surg Neurol Int"},{"key":"518_CR35","first-page":"579","volume":"19","author":"JB Posner","year":"1978","unstructured":"Posner JB, Chernik NL. Intracranial metastases from systemic cancer. Adv Neurol. 1978;19:579\u201392.","journal-title":"Adv Neurol"},{"key":"518_CR36","first-page":"733","volume":"61","author":"WR Shapiro","year":"1977","unstructured":"Shapiro WR, Posner JB, Ushio Y, et al. Treatment of meningeal neoplasms. Cancer Treat Rep. 1977;61:733\u201343.","journal-title":"Cancer Treat Rep"},{"key":"518_CR37","doi-asserted-by":"crossref","first-page":"6e","DOI":"10.1177\/030089161309900124","volume":"99","author":"D Cante","year":"2013","unstructured":"Cante D, Franco P, Sciacero P, et al. Leptomeningeal metastasis from prostate cancer. Tumori. 2013;99:6e\u201310e.","journal-title":"Tumori"},{"key":"518_CR38","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1308\/147870811X602104","volume":"93","author":"RP Lahiri","year":"2011","unstructured":"Lahiri RP, Burnand KM, Bandi A, et al. Colorectal cancer presenting with dysarthria and ataxia: a case of isolated leptomeningeal metastasis. Ann R Coll Surg Engl. 2011;93:e133\u20135.","journal-title":"Ann R Coll Surg Engl"},{"key":"518_CR39","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1007\/s12032-011-0076-9","volume":"29","author":"E Miller","year":"2012","unstructured":"Miller E, Dy I, Herzog T. Leptomeningeal carcinomatosis from ovarian cancer. Med Oncol. 2012;29:2010\u20135.","journal-title":"Med Oncol"},{"key":"518_CR40","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.3748\/wjg.15.5086","volume":"15","author":"SY Oh","year":"2009","unstructured":"Oh SY, Lee SJ, Lee J, et al. Gastric leptomeningeal carcinomatosis: multi-center retrospective analysis of 54 cases. World J Gastroenterol. 2009;15:5086\u201390.","journal-title":"World J Gastroenterol"},{"key":"518_CR41","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.clineuro.2012.02.007","volume":"114","author":"E Onesti","year":"2012","unstructured":"Onesti E, Fabi A, Mingoia M, et al. Leptomeningeal carcinomatosis in aggressive germ non-seminoma testicular tumor: a case report and review of literature. Clin Neurol Neurosurg. 2012;114:1081\u20135.","journal-title":"Clin Neurol Neurosurg"},{"key":"518_CR42","first-page":"1917","volume":"39","author":"S Kashiwagi","year":"2012","unstructured":"Kashiwagi S, Asano Y, Watanabe M, et al. Four cases of meningeal metastasis originating from breast cancer. Gan To Kagaku Ryoho. 2012;39:1917\u20139.","journal-title":"Gan To Kagaku Ryoho"},{"key":"518_CR43","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/CAD.0b013e32830b58b0","volume":"19","author":"HJ Stemmler","year":"2008","unstructured":"Stemmler HJ, Mengele K, Schmitt M, et al. Intrathecal trastuzumab (Herceptin) and methotrexate for meningeal carcinomatosis in HER2-overexpressing metastatic breast cancer: a case report. Anticancer Drugs. 2008;19:832\u20136.","journal-title":"Anticancer Drugs"},{"key":"518_CR44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0090-8258(84)90015-5","volume":"18","author":"AN Gordon","year":"1984","unstructured":"Gordon AN, Kavanagh JJ Jr, Wharton JT, et al. Successful treatment of leptomeningeal relapse of epithelial ovarian cancer. Gynecol Oncol. 1984;18:119\u201324.","journal-title":"Gynecol Oncol"},{"key":"518_CR45","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1023\/A:1013532930596","volume":"12","author":"AF Ferreira Filho","year":"2001","unstructured":"Ferreira Filho AF, Cardoso F, Di Leo A, et al. Carcinomatous meningitis as a clinical manifestation of pancreatic carcinoma. Ann Oncol. 2001;12:1757\u20139.","journal-title":"Ann Oncol"},{"key":"518_CR46","first-page":"256","volume":"12","author":"MT Grira","year":"2007","unstructured":"Grira MT, Ben Jemaa HM, Lammouchi TM, et al. Meningitis revealing pancreatic carcinoma. Neurosciences (Riyadh). 2007;12:256\u20138.","journal-title":"Neurosciences (Riyadh)"},{"key":"518_CR47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12029-009-9120-9","volume":"41","author":"A Minchom","year":"2010","unstructured":"Minchom A, Chan S, Melia W, et al. An unusual case of pancreatic cancer with leptomeningeal infiltration. J Gastrointest Cancer. 2010;41:107\u20139.","journal-title":"J Gastrointest Cancer"},{"key":"518_CR48","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1086\/383129","volume":"189","author":"KL Tyler","year":"2004","unstructured":"Tyler KL, Barton ES, Ibach ML, et al. Isolation and molecular characterization of a novel type 3 reovirus from a child with meningitis. J Infect Dis. 2004;189:1664\u201375.","journal-title":"J Infect Dis"},{"key":"518_CR49","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/mt.2014.21","volume":"22","author":"KP Kicielinski","year":"2014","unstructured":"Kicielinski KP, Chiocca EA, Yu JS, et al. Phase 1 clinical trial of intratumoral reovirus infusion for the treatment of recurrent malignant gliomas in adults. Mol Ther. 2014;22:1056\u201362.","journal-title":"Mol Ther"},{"key":"518_CR50","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/sj.mt.6300403","volume":"16","author":"P Forsyth","year":"2008","unstructured":"Forsyth P, Roldan G, George D, et al. A phase I trial of intratumoral administration of reovirus in patients with histologically confirmed recurrent malignant gliomas. Mol Ther. 2008;16:627\u201332.","journal-title":"Mol Ther"},{"key":"518_CR51","first-page":"645","volume":"26","author":"SH Alloussi","year":"2011","unstructured":"Alloussi SH, Alkassar M, Urbschat S, et al. All reovirus subtypes show oncolytic potential in primary cells of human high-grade glioma. Oncol Rep. 2011;26:645\u20139.","journal-title":"Oncol Rep"},{"key":"518_CR52","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/jnci\/93.12.903","volume":"93","author":"ME Wilcox","year":"2001","unstructured":"Wilcox ME, Yang W, Senger D, et al. Reovirus as an oncolytic agent against experimental human malignant gliomas. J Natl Cancer Inst. 2001;93:903\u201312.","journal-title":"J Natl Cancer Inst"},{"key":"518_CR53","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1053\/ctrv.1999.0119","volume":"25","author":"SA Grossman","year":"1999","unstructured":"Grossman SA, Krabak MJ. Leptomeningeal carcinomatosis. Cancer Treat Rev. 1999;25:103\u201319.","journal-title":"Cancer Treat Rev"},{"key":"518_CR54","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<733::AID-CNCR17>3.0.CO;2-Z","volume":"82","author":"MJ Glantz","year":"1998","unstructured":"Glantz MJ, Cole BF, Glantz LK, et al. Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer. 1998;82:733\u20139.","journal-title":"Cancer"},{"key":"518_CR55","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM197507242930402","volume":"293","author":"WR Shapiro","year":"1975","unstructured":"Shapiro WR, Young DF, Mehta BM. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med. 1975;293:161\u20136.","journal-title":"N Engl J Med"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-014-0518-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-014-0518-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-014-0518-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T15:45:32Z","timestamp":1565711132000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-014-0518-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,6]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["518"],"URL":"https:\/\/doi.org\/10.1007\/s12328-014-0518-y","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,6]]}}}